Literature DB >> 26989717

Construction and eukaryotic expression of recombinant large hepatitis delta antigen.

Behnaz Forouhar Kalkhoran1, Farida Behzadian2, Farzaneh Sabahi1, Mohsen Karimi3, Hesam Mirshahabi1.   

Abstract

BACKGROUND: Hepatitis delta virus (HDV) is a subviral human pathogen that exploits host RNA editing activity to produce two essential forms of the sole viral protein, hepatitis delta antigen (HDAg). Editing at the amber/W site of HDV antigenomic RNA leads to the production of the large form (L-HDAg), which is required for RNA packaging.
METHODS: In this study, PCR-based site-directed mutagenesis by the overlap extension method was used to create the point mutation converting the small-HDAg (S-HDAg) stop codon to a tryptophan codon through three stages.
RESULTS: Sequencing confirmed the desirable mutation and integrity of the L-HDAg open reading frame. The amplicon was ligated into pcDNA3.1 and transfected to Huh7 and HEK 293 cell lines. Western blot analysis using enhanced chemiluminescence confirmed L-HDAg expression. The recombinant L-HDAg localized within the nuclei of cells as determined by immunofluorescence and confocal microscopy.
CONCLUSION: Because L-HDAg requires extensive post-translational modifications, the recombinant protein expressed in a mammalian system might be fully functional and applicable as a tool in HDV molecular studies, as well as in future vaccine research.

Entities:  

Keywords:  Hepatitis Delta Virus; L-HDAg; SOEing-PCR

Year:  2013        PMID: 26989717      PMCID: PMC4757064     

Source DB:  PubMed          Journal:  Rep Biochem Mol Biol        ISSN: 2322-3480


  16 in total

1.  Increased RNA editing and inhibition of hepatitis delta virus replication by high-level expression of ADAR1 and ADAR2.

Authors:  Geetha C Jayan; John L Casey
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Molecular cloning of hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure, and applications.

Authors:  M Y Kuo; J Goldberg; L Coates; W Mason; J Gerin; J Taylor
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

3.  Continuous expression and replication of the hepatitis delta virus genome in Hep G2 hepatoblastoma cells transfected with cloned viral DNA.

Authors:  P J Chen; M Y Kuo; M L Chen; S J Tu; M N Chiu; H L Wu; H C Hsu; D S Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

4.  Hepatitis delta virus RNA editing is highly specific for the amber/W site and is suppressed by hepatitis delta antigen.

Authors:  A G Polson; H L Ley; B L Bass; J L Casey
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

5.  Introduction of hepatitis delta virus into animal cell lines via cationic liposomes.

Authors:  V Bichko; H J Netter; J Taylor
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

6.  Assembly of hepatitis delta virus particles.

Authors:  W S Ryu; M Bayer; J Taylor
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

7.  In vitro replication of hepatitis D virus using a new construct containing a cDNA dimer of HDV genome.

Authors:  Farida Behzadian; Farzaneh Sabahi; Majid Sadeghizadeh; Nader Maghsoudi; Fatemeh Fotouhi; Fatemeh Fotouhi Chahooki; Mohsen Karimi
Journal:  Intervirology       Date:  2007-10-31       Impact factor: 1.763

8.  Hepatitis delta virus: protein composition of delta antigen and its hepatitis B virus-derived envelope.

Authors:  F Bonino; K H Heermann; M Rizzetto; W H Gerlich
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

9.  delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees.

Authors:  M Rizzetto; B Hoyer; M G Canese; J W Shih; R H Purcell; J L Gerin
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

10.  Hepatitis delta virus RNA encoding the large delta antigen cannot sustain replication due to rapid accumulation of mutations associated with RNA editing.

Authors:  Thomas B Macnaughton; Yi-Ija Li; Alison L Doughty; Michael M C Lai
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.